Canadian Online Pharmacy

CDER New June 4, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 3, 2013


New and Generic Drug Approvals

May 31, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Bloxiverz neostigmine methylsulfate Injectable; Injection Eclat Pharma Approval
Humulin 70/30 insulin recombinant human; insulin susp isophane recombinant human Injectable; Injection Lilly Manufacturing Change or Addition
Humulin 70/30 Pen insulin recombinant human; insulin susp isophane recombinant human Injectable; Injection Lilly Manufacturing Change or Addition
Humulin N insulin susp isophane recombinant human Injectable; Injection Lilly Manufacturing Change or Addition
Humulin R insulin recombinant human Injectable; Injection Lilly Manufacturing Change or Addition
Humulin R Pen insulin recombinant human Injectable; Injection Lilly Manufacturing Change or Addition
Rebetol ribavirin Capsule; Oral Merck Sharp Dohme Labeling Revision
Rebetol ribavirin Solution; Oral Schering Labeling Revision
Restasis cyclosporine Emulsion; Ophthalmic Allergan Manufacturing Change or Addition
Veregen sinecatechins Ointment; Topical Medigene Ag Manufacturing Change or Addition
Vibativ telavancin hydrochloride Powder; Iv (Infusion) Theravance Inc Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery